We are live on
!
Find out more
CASI
CASI Pharmaceuticals
CASI
CASI
Delisted
CASI was delisted on the 25th of February, 2026.
27 hedge funds and large institutions have $2.41M invested in CASI Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
8% more funds holding
Funds holding: 25 → 27 (+2)
0.01% less ownership
Funds ownership: 0.39% → 0.38% (-0.01%)
25% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 8
27% less capital invested
Capital invested by funds: $3.33M → $2.41M (-$914K)
Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$22K |
| 2 |
BlackRock
New York
|
+$19.1K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$6.71K |
| 5 |
Creative Planning
Overland Park,
Kansas
|
+$1.57K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$62K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$39K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$15.5K |
| 4 |
Renaissance Technologies
New York
|
-$6.94K |
| 5 |
WSCM
Wellington Shields Capital Management
New York
|
-$2.53K |
